Document is current
Any future updates will be listed below
-
Authors
Albites-Sanabria, Jose
Palumbo, Pierpaolo
Bandinelli, Stefania
D’Ascanio, Ilaria
Mellone, Sabato
Paraschiv-Ionescu, Anisoara
Küderle, Arne
Cereatti, Andrea
Del Din, Silvia
Kluge, Felix
Gazit, Eran
Jansen, Carl-Philipp
Delgado-Ortiz, Laura
Garcia-Aymerich, Judith
Rochester, Lynn
Klenk, Jochen
Ferrucci, Luigi
Becker, Clemens
Chiari, Lorenzo
Palmerini, Luca
-
Funding
Funding for this research was provided by:
Seventh Framework Programme (288940)
Horizon 2020 (820820)
Horizon 2020 (820820)
Horizon 2020 (820820)
Horizon 2020 (820820)
Horizon 2020 (820820)
Horizon 2020 (820820)
Horizon 2020 (820820)
Horizon 2020 (820820)
Horizon 2020 (820820)
Horizon 2020 (820820)
Horizon 2020 (820820)
Horizon 2020 (820820)
Horizon 2020 (820820)
Horizon 2020 (820820)
Horizon 2020 (820820)
Horizon 2020 (820820)
- License Information
-
More Information
Article History
Received: 24 March 2025
Accepted: 6 June 2025
First Online: 5 July 2025
Competing interests
: S.M., L.P. and L.C. are co-founders and own shares of mHealth Technologies. S.D.D. reports consultancy activity with Hoffmann-La Roche Ltd. outside of this study. The remaining authors declare no competing interests.
